Huntington National Bank’s Oncolytics Biotech ONCY Stock Holding History

Huntington National Bank’s Portfolio ONCY Stock Details ONCY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-1,052	Closed	–	–	1822
2019 Q3	$0	Hold	1,052	–	–	﹤0.01%	1700
2019 Q2	$2K	Hold	1,052	–	–	﹤0.01%	1506
2019 Q1	$2K	Hold	1,052	–	–	﹤0.01%	1486
2018 Q4	$2K	Buy	+1,052	New	+$2.85K	﹤0.01%	1567

Other funds holding ONCY

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Scotia Capital Toronto, Ontario, Canada $24.3B AUM 29.21% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

CIBC World Market Toronto, Ontario, Canada $61.3B AUM 39.33% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

CGA

Crescent Grove Advisors Lake Forest, Illinois $1.04B AUM 17.78% 1-Year Est. Return

Comerica Bank Dallas, Texas $25.1B AUM 24.68% 1-Year Est. Return

LTFS

Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return

Huntington National Bank's ONCY Position: Q4 2019 in Review

Huntington National Bank sold out of Oncolytics Biotech (ONCY) in Q4 2019, closing a stake of 1,052 shares.

Huntington National Bank first reported a position in ONCY in Q4 2018 and held it in 4 quarters. The position peaked at $2K in Q2 2019. 28 funds tracked by Wall St. Rank hold ONCY as of Q4 2019.

Huntington National Bank reported no remaining Oncolytics Biotech position as of Q4 2019 after selling out during the quarter.
Huntington National Bank sold 1,052 Oncolytics Biotech shares in Q4 2019.
Huntington National Bank first reported a position in Oncolytics Biotech in Q4 2018 and held it in 4 quarters.
Huntington National Bank's Oncolytics Biotech position peaked at $2K in Q2 2019.
28 funds tracked by Wall St. Rank held Oncolytics Biotech as of Q4 2019.

Based on Huntington National Bank's 13F filing for Q4 2019, filed 17 Jan 2020.